Eugenol, the major constituent of clove oil, has been widely used for its anesthetic and analgesic action in dentistry. Eugenol exhibits pharmacological effects on almost all systems and our aim is to review the research work that has identified these pharmacological actions. Eugenol possesses significant antioxidant, anti-inflammatory and cardiovascular properties, in addition to analgesic and local anesthetic activity. The metabolism and pharmacokinetics of the compound in humans have been studied. Eugenol has also been used as a penetration enhancer. The compound is a very promising candidate for versatile applications, and the design of new drugs based on the pharmacological effects of eugenol could be beneficial.
inhibition of lipid peroxidation at the level of initiation [12] . Vidhya and coworkers investigated the short and long term antioxidant activities of eugenol (1000 mg/ kg) on rat intestine and observed that the compound helps in the removal of toxic materials from the intestine as it caused the induction of glutathione-Stransferases [13] . Antioxidants and free radical scavengers like eugenol have also been monitored as agents for preventing the progress of Parkinson disease. A study demonstrated that eugenol (0.1 -1.0 µM/kg) inhibits lipid peroxidation and thereby suppresses 6hydroxydopamine-induced dopamine depression thereby suggesting its potential use in Parkinson disease [14] . The antioxidant activity of eugenol is comparable with that of butylated hydroxyanisole and butylated hydroxytoluene [15] . Although many in vitro studies have been carried out on the antioxidant activity of eugenol, there have been insufficient in vivo studies.
Protective effect: Eugenol modulates both the NMDA receptor and superoxide radical and thus seems to provide protection against ischemic injury. Eugenol can attenuate NMDA induced acute neurotoxicity and decrease xanthine/xanthine oxidase produced oxidative neuronal injury [16] . Eugenol (10.7 mg/kg/day) has been found to show an in vivo antioxidant property and a better inducing effect on phase II enzymes which counteract the metabolizing enzyme reduction caused by carbon tetrachloride [17] . In vitro studies on liver microsomal monooxygenase activities and carbon tetrachloride (CCl 4 )-induced lipid peroxidation have shown that eugenol inhibits both [18] . The in vivo studies by the same researchers also showed a protective effect of eugenol at doses of 5 and 25 mg/kg against CCI 4 induced hepatotoxicity. The methanolic extract of leaves of Ocimum suave (Lamiaceae), which contains eugenol as a major constituent [19] , has shown gastric cytoprotective and anti-ulcer effects in experimental Wistar rats [20] . Eugenol pre-treatment (10-100 mg/kg) reduces both the number of gastric ulcers and the gravity of lesions induced by ulcerogenic agents like platelet activating factor and ethanol [21] . The mechanism of the gastroprotective action of eugenol has been established by the studies of Morsy and Fouad [22] . Gastric mucosal lesions, gastric acid outputs and pepsin activity in male Sprague-Dawley rats were markedly reduced by a single oral dose of eugenol (100 mg/kg), used as a pretreatment one hour before indomethacin injection. This pretreatment resulted in a marked increase in mucin concentration, suppression of the rise in gastric mucosal malondialdehyde and total nitrite, and attenuation of the decrease in reduced glutathione. It was further confirmed that the protective action of eugenol is through opening of ATP-sensitive potassium channels and not through the transient receptor potential vanilloid 1. The DNA-protective activity of eugenol has been observed by Yogalakshmi and coworkers in thioacetamide-induced liver injury in rats at a dose of 10.7 mg/kg/day [23] . Eugenol imparts a dose dependent protection against nicotine-induced superoxide mediated oxidative damage at a concentration range of 1-20 µg/mL [24] .
Anesthetic action:
A randomized, single-blind study was carried out in 73 subjects to evaluate the topical anesthetic action of clove oil in comparison with benzocaine [1] . The pain scores between the clove gel and the benzocaine groups were not significantly different, but were significantly lower than those of the placebo groups. The study showed that clove gel is a cheap and easily available topical anesthetic which could be used as an alternative to benzocaine gel in dentistry. A reversible, dose dependent anesthesia has also been reported after eugenol administration (5 -60 mg/kg, iv) in male Sprague-Dawley rats [5] .A clinical study was conducted in 100 adult patients to study the effect of eugenol as an intravenous anesthetic. However, they concluded that it is not advisable to use eugenol except in special circumstances as the incidence of development of venous thrombosis around the site of injection was high [25] . The possible use of eugenol as a local anesthetic has also been demonstrated by the studies of Park and coworkers, who suggested its suitability for non-dental anesthesia as well [26] .
Antibacterial, antifungal and antiviral activities:
The activity has been studied of Eugenia aromaticum on several microorganisms and parasites, including pathogenic bacteria, and herpes simplex and hepatitis C viruses [27] . Burt and coworkers studied the antibacterial activity of clove bud oil and found it to be effective [28] . Eugenol is active against Neisseria gonorrhoeae, with a minimum inhibitory concentration of 85-256 mg/L [29] . Moreover, eugenol shows synergistic effects with antibiotics against Gramnegative bacteria [30] . Mytle and coworkers have demonstrated the ability of clove oil to inhibit the growth Listeria monocytogenes. A 1% v/w concentration was sufficient for the inhibition of growth at 5 o C and 15 o C [31] . Eugenol was found to be active against sessile cells in Candida albicans biofilms [32] . The compound showed fungicidal activity in vitro for exponentially growing Candida albicans. The mechanism of this action was found to be through envelope damage [33] . In the in vivo study, treatment with eugenol caused a significant reduction in the colony count number in an immunosuppressed rat model of oral candidiasis in comparison with the untreated control group [34] . Chami and coworkers also evaluated eugenol in an immunosuppressed rat model of vaginal candidiasis for its efficacy in the prophylaxis
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Eugenol can cause damage to viral envelopes of freshly formed virons and can cause inhibition of viral replication at the initial stage [37] . The anti-viral activity of eugenol, clove flower bud extract and clove essential oil against Herpes simplex virus has been carried out [37] . Direct inactivation of viruses and inhibition of intracellular and extracellular viruses after replication were observed with eugenol. In another study for antiviral activity against HSV-1 and HSV-2 viruses [38] , 50% inhibitory concentration values were 25.6 μg/mL and 16.2 μg/mL for HSV-1 and HSV-2, respectively. Eugenol demonstrated a synergistic action with acyclovir against in vitro replication of herpes virus. Topical eugenol therapy was observed to suppress herpes virus induced keratitis in mouse.
Anticonvulsant activity: Zelger and coworkers investigated
the anticonvulsant activity of phenyleugenol, benzyleugenol and phenylethyleugenol, which are synthetic derivatives of eugenol [39] . All three compounds showed significant anticonvulsant activity in the maximal electroshock seizure test. Phenyleugenol and benzyleugenol were found to have a high therapeutic index. All these studies indicated that eugenol could be taken as a lead molecule in the development of novel anticonvulsant drugs.
Anti-inflammatory action:
Eugenol inhibits cycloxygenase and thus inhibits prostaglandin H synthase [40] . This can be the result of its competition with arachidonic acid. Eugenol is able to resist the release of proinflammatory mediators like interleukin-1β, tumor necrosis factor-α and prostaglandin E2 from macrophages and is thus useful for acute inflamed dental pulps and apical periodontitis as an antiinflammatory agent [41] . Eugenol can also inhibit cycloxygenase-2 in macrophages. Eugenol caused reduction of both paw and joint swelling in arthritis induced male Sprague-Dawley rats at a dose of 33 mg/kg [42] . An in vivo study by Rodrigues and coworkers on the effect of an hydroalcoholic extract of clove on pro-inflammatory cytokines production by macrophages of mice showed that clove oil (200 mg/kg) caused cytokine inhibition due to the presence of eugenol, which imparts an anti-inflammatory activity [43] . The in vivo anti-inflammatory activity of eugenol in lipopolysaccharide induced lung injury has been demonstrated on administration of 160 mg/kg, ip [44] .
Penetration enhancement: The utility of clove oil (82.6% eugenol) as a penetration enhancer has been demonstrated by Shen and coworkers [45] . Permeation enhancement was found to be significant both in vivo and in vitro. The in vivo effect observed was comparatively weaker than that observed in vitro. A marked increase in drug flux was observed with clove oil in in vivo percutaneous absorption studies in rabbit. All the results suggested the potential ability of clove oil, of which eugenol is the major active component, as a penetration enhancer in transdermal drug delivery systems [45] . In vitro evaluation of penetration enhancers, including eugenol, has been conducted by Mutalik and coworkers using mouse skin [46] . In their study, eugenol was also found to increase skin retention and solubility of glibenclamide and glipizide. Zhao and coworkers studied the in vitro penetration enhancement effect of eugenol on percutaneous absorption of a drug through porcine epidermis [47] . The study showed that eugenol was able to enhance markedly the permeability coefficient of tamoxifen with respect to the control group. The study also found that lipid extraction and increased partitioning of the tamoxifen to the stratum corneum is responsible for the observed permeability enhancement action of eugenol.
Cardiovascular actions: Eugenol (0.2 -20 µmol) produces dose-dependent, reversible vasodilator responses that are partially dependent on the endothelium [48] . Sensch and coworkers showed that eugenol (60 -600 µmol/L) exerted negative inotropic effects in heart muscle of Guinea-pig [49] . The effect was found to be comparable with that of nifedipine, a calcium channel blocker. Eugenol (0.006 -6 mM) causes hypotensive effects in hypertensive rats due to vascular relaxation [50] . The blocking of voltagesensitive and receptor-operated channels by eugenol is responsible for its smooth muscle relaxant effect and these actions are mediated through endothelialgenerated nitric oxide [51] . Choudhary and coworkers observed eugenol to counteract isoproterenol-induced cardiac hypertrophy [52] . They conducted their study in male Wister rats using a dose of 1 mg/kg twice daily. They showed that serum calcineurin activity in vitro was suppressed by eugenol, and isoproterenol-induced oxidative stress and apoptosis were reduced. Eugenol was also found to increase cardiac calcineurin and protein kinase C activity in ventricular tissue to normal values.
Anticancer activity: Significant induction of activity of glutathione S-transferase by eugenol was observed in liver and small intestine [53] . Miyazawa and coworkers showed that due to the presence of a C-4 hydroxy group in their structure, trans-isoeugenol and eugenol had significant suppressive effects on the SOS-inducing activity of chemical mutagens such as furylfuramide [54] . The antimutagenic effects of a eugenol derivative, dehydroeugenol, have also been demonstrated by the same authors. Studies have demonstrated that eugenol provides protection from chemical induced skin cancer [55, 56] .
Other pharmacological actions: An antigenotoxic effect of eugenol was studied in humans by Rompelberg and coworkers [57] , but no evidence was observed for these effects. Tajuddin and coworkers investigated the effect of a 50% ethanolic extract of clove on sexual function improvement in male Swiss mice (500 mg/kg) and observed an enhanced sexual behavior of the mice [58] .
Molecular mechanisms and biochemical changes:
Eugenol showed inhibition of high-voltage-activated calcium channel currents in both capsaicin-sensitive and capsaicin-insensitive dental primary afferent neurons [59] . However, the action of eugenol was unaffected by capsazepine. This suggested that the action is not mediated by transient receptor potential vanilloid 1 activation. N-type calcium currents were inhibited by eugenol in the cell line C2D7. The study showed that high-voltage-activated calcium channel current inhibition in dental primary afferent neurons by eugenol is responsible for its dental analgesic action. The mechanism of anesthetic action of eugenol by inhibition of sodium channel currents has been established by the whole-cell patch-clamp method in rat dental primary afferent neurons [60] . Capsaicin-sensitive and capsaicin-insensitive neurons are both inhibited by eugenol and its irritable action is possibly due to the inhibition of voltage-gated K + currents [61] . Yang and coworkers showed that eugenol produces its effects in the sensory nerve endings in the teeth through vanilloid receptor 1, at least partially [62] .
The analgesic effect of eugenol is probably due to the inhibition of Ca(V)2.3 calcium channels. A study by Chung and coworkers showed that the mechanism of inhibition of Ca(V)2.3 calcium channels by eugenol is not involved through transient receptor potential vanilloid 1 and thus appeared to be distinctly different from that of capsaicin [63] . Both capsaicin receptor mediated and capsaicin receptor independent pathways are involved in the activation of Ca 2+ channels by eugenol [64] . Eugenol has the ability to inhibit proinflammatory mediators like nitric oxide synthase, lipoxygenase and cyclooxygenase. Eugenol exerts its analgesia by inhibition of Na + currents and the inhibition is independent of the stimulus frequency [65] . Inotropic effects of eugenol have been investigated in rat left ventricular papillary muscles by Damiani and coworkers [66] . The contraction force was depressed without affecting the contractile machinery. Complete blockade of inward Ca 2+ current was observed with 0.5 mM of eugenol. Xu and coworkers explained that the transient receptor potential vanilloid 3 is expressed by eugenol. It is a warm-sensitive Ca 2+ -permeable cation channel in the skin, tongue and nose [67] .
Eugenol has been reported to potentiate the GABA response. The compound's ability to potentiate GABAA receptors can modulate neural transmission in the brain just like, for example, benzodiazepine and barbiturate [68] . Salah and coworkers showed that eugenol causes effects such as relaxation of rat ileal strip, reduced intestinal transit in rats, and the potentiation of the diarrhea inducing effect of castor oil [69] . They suggested that all these effects are mediated through Ca 2+ channel modulation. Eugenol accelerates inactivation of the Ca 2+ current in isolated canine and human ventricular cardiomyocytes [70] .
Metabolism and pharmacokinetics:
Fischer and coworkers investigated the metabolism of eugenol in male and female healthy volunteers [71] . The study revealed that eugenol is rapidly absorbed and metabolized after oral administration. It is almost completely excreted in the urine within 24 hours. Only less than 0.1% of the administered dose was excreted unmetabolized in urine. Eugenol was found in the urine in the form of conjugates and metabolites. Among the metabolite conjugates, 55% consisted of eugenolglucuronide and sulfate. The epoxide-diol pathway, allylic oxidation, synthesis of a thiophenol and a substituted propionic acid, and migration of the double bond were also found to be other routes of eugenol metabolism in humans. A study was made by Guénette and coworkers of the pharmacokinetic parameters of eugenol using non-compartmental analysis after gavage administration in male Sprague-Dawley rats in a dose of 40 mg/kg [6] . Plasma T 1/2 of eugenol was found to be 14.0 hours and blood T 1/2 was 18.3 hours. Glucuronide and sulfate conjugates of eugenol in urine after eugenol administration were also identified in male Sprague-Dawley rats [5] .
Toxicity:
The prooxidant activity of eugenol may be responsible for its toxicity [72] . An in vitro study by Medeiros and coworkers demonstrated that the binding of lysine to eugenol might lead to protein inactivation and consequently to its toxicity [73] . The insecticidal activity of eugenol also has been reported [2] .
A summary is given in Table 1 of the various research carried out to demonstrate the different pharmacological activities of eugenol and clove oil. Further research is required to collect more information about the pharmacological effects of eugenol, and also to find new areas of therapeutic applications. A detailed knowledge of eugenol pharmacology could be utilized Eugenol -pharmacological actions Natural Product Communications Vol. 5 (12) CLOVE OIL DPPH scavenging activity Activity similar to BHA & BHT (0.5 µg/mL) [15] Hydroxyl radical scavenging Active more than quercetin (0.2 μg/mL) [15] Antioxidant Lipid peroxidation Active more than BHT [15] Anti-inflammatory Mice Caused cytokine inhibition (200 mg/kg) [43] Excised rabbit abdominal skin Significant increase in drug flux (1-3 %) [ 
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Suppressive effect on mutagens (ethyl acetate extract) [54] Aphrodisiac Male Swiss mice Improved sexual function (500 mg/kg of 50 % ethanolic extract) [58] to consider eugenol as a lead molecule for the development of new drugs [74] with enhanced therapeutic efficacy.
